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The effects ofphentolamine, 0 3 mg/min given intravenously for 15 minutes, on His bundle electrograms were studied in 11 patients with heart disease. Recordings were made at varied heart rates, using atrial pacing.
Phentolamine significantly reduced the AH interval in every patient but it had no effect on the HV interval.
Functional and effective refractory periods were measured with the use of the atrial extrastimulus technique. The effective refractory period of the atrium and atrioventricular node as well as the functional refractory period of the atrioventricular node all significantly decreased after phentolamine infusion. This improvement in conduction is probably mediated by a release of catecholamines.
In his experimental work on dogs, Leimdorfer (1952) showed that the intravenous administration ofphentolamine prevented the induction of arrhythmias by nicotine sulphate and adrenaline, and converted methacholine-induced atrial flutter to normal sinus rhythm. He further showed that phentolamine administration prevented the appearance of pronounced bradycardia during electrical stimulation of the vagus nerve. Vargaftig and Coignet (1969) showed that the appearance of aconitine-induced arrhythmias in rats was delayed by phentolamine, and, in addition, ventricular fibrillation caused by chloroform inhalation in mice was blocked by phentolamine.
The antiarrhythmic effect of phentolamine was investigated in 10 normal dogs acutely digitalised with ouabain (Ettinger et al., 1969) . Phentolamine was infused for an average of 10 minutes at 03 mg/min. Ventricular arrhythmias were abolished in 7 of 8 dogs and the rate was increased in 1 dog with sinus bradycardia. It was subsequently reported that the intravenous administration of phentolamine could successfully suppress digitalis or non-digitalis induced ventricular premature beats in man . Similarly, phentolamine infused at a rate of 0 3 mg/min for 15 minutes decreased or abolished supraventricular premature beats in 22 of 30 patients (Gould et al., 1972) . The oral administration of phentolamine was also effective in suppressing ventricular premature beats in cardiac patients without an acute myocardial infarction Received for publication 4 January 1977 . Recently the effectiveness of phentolamine therapy for the prevention of cardiac arrhythmias was determined in a double blind study of 39 patients with uncomplicated acute myocardial infarction (Gould et al., 1975) . Phentolamine, 50 mg, or placebo was administered orally 4 times a day for 5 days. Phentolamine afforded a highly significant protection from ventricular premature beats and supraventricular premature beats.
The effect of phentolamine on atrioventricular conduction has been studied in patients using the His bundle electrogram technique. A shortening of the AH interval, which signifies an improvement in atrioventricular conduction, was found by two groups of workers (Khan et al., 1972; Gould et al., 1974) . However, no study has been reported of its effect on the refractory periods of the atrium and atrioventricular node as determined by the extrastimulus method.
The present study, involving 11 human subjects, was undertaken to determine what effects intravenously administered phentolamine has on refractoriness of the atrium and atrioventricular node at paced cycle lengths. Measurements were also made of the atrioventricular nodal and His-Purkinje conduction time over a range of paced atrial beats.
Subjects and methods
The study group consisted of 11 patients with heart disease. The clinical features of the group are 939 The refractory periods of the atrium, atrioventricular node, and His-Purkinje system were determined by the extrastimulus method (Wit et al., 1970) . A cycle length approximately 20 per cent faster than the sinus rate was used so that refractory periods could be measured at identical cycle lengths before and after administration of phentolamine. The following intervals were measured in milliseconds.
(1) PA INTERVAL The interval from the onset of the P wave during normal sinus conduction recorded on the standard electrocardiographic lead to the first rapid deflection of the A wave on the bipolar electrogram. The PA time represents intra-atrial conduction time. The normal value is 27±18 ms (Rosen, 1972) . During atrial pacing the PA time is measured from the pacing impulse to A.
(2) AH INTERVAL The interval from the first rapid deflection of the A wave to the first rapid deflection of the bundle of His electrogram. The AH time represents conduction time through the AV node. The normal value is 92 ±38 ms (Rosen, 1972) .
The interval from the first rapid bundle of His deflection to the onset of the QRS deflection in the electrocardiogram. The HV interval approximates conduction time in the specialised tissues of the HisPurkinje system. The normal value is 43±12 ms (Rosen, 1972) .
For the assessment of each of these intervals, measurements were made from 10 beats before and after the administration of phentolamine, and the mean values were used for comparison. In addition, the recovery time of the sinus node pacemaker, after sudden cessation of the highest pacing rate obtained, was observed before and after the drug.
The following definitions were used in regard to refractory periods: A1, H1, and V1 were the atrial, His bundle, and ventricular electrograms of driven beats (Si). A2, H2, and V2 were the atrial, His bundle, and ventricular electrograms in response to the extrastimulus (S2). The atrial effective refractory period was the longest S1-S2 interval at which S2 did not result in atrial depolarisation. The atrioventricular nodal effective refractory period was the longest A1-A2 interval at which A2 failed to conduct to the bundle of His. The atrioventricular nodal functional refractory period was the shortest interval between H1-H2, both of which were propagated from the atrium. (beats/min) HR, heart rate; NS, not significant; C, control; P, phentolamine.
Phentolamine was then infused intravenously at 0 3 mg/min for 15 minutes and the electrophysiological studies were repeated. The blood pressure was also obtained, with a sphygmomanometer, before and after the administration of phentolamine. Statistical analysis of all data was performed using the Student's t test for paired data.
Results
The effects of phentolamine on the conduction system are presented in Tables 2 and 3 . (Fig. 2) .
INTRAVENTRICULAR CONDUCTION
The HV intervals were not changed in any patient by the administration of phentolamine.
AUTOMATICITY AND RECOVERY PERIODS OF SINUS NODE
The sinus rate increased in all patients. The mean sinus rate was 69±6 beats/min before and 74±6 beats/min after phentolamine (P < 0.001). Sinus node recovery times decreased after phentolamine. Mean recovery times before and after phentolamine were 1060 ±76 ms and 1021 ±78 ms, respectively (NS).
BLOOD PRESSURE
The blood pressure fell in every patient after phentolamine administration. The mean values were respectively 145/83 8/4 mmHg before and 130/70 ±6/3 mmHg after phentolamine (P < 0-01).
Discussion
The present study revealed that phentolamine administration produced a significant reduction in the AH interval in the control state as well as at the various atrial pacing rates. In a previous report from this laboratory, phentolamine was found consistently to enhance atrioventricular nodal conduction in man (Gould et al., 1974) . In keeping with those findings is the fact that in this study the functional refractory period of the atrioventricular node decreased in all patients. Further, the effective refractory period of the atrioventricular node also shortened in the 7 patients in whom this interval could be measured. Phentolamine did not affect His Purkinje conduction time (HV interval) during sinus rhythm or over a wide range of paced atrial rates. The PA interval, a measure of conduction from the high to low right atrium, was unaltered after the administration of phentolamine. It is of interest that the effective refractory period of the atrium showed a small but significant decrease after phentolamine administration. Phentolamine can increase the availability of endogenous catecholamines to the heart. This contention is supported by the work of Dairman et al. (1968) . They administered phentolamine 5 mg/kg to rats; at the height of receptor blockade, the conversion of a tracer dose of 14 Ctyrosine to norepinephrine was increased threefold, with no alteration in specific activity of tyrosine in blood and tissues. From these studies Dairman and his coworkers concluded that receptor blockade led to increased synthesis and release of noradrenaline in the three organs that were measured. Bagwell et al. (1970) administered 5 mg/kg of phentolamine to seven experimental animals and observed an increase in the left ventricular contractile force. If the animals were pretreated with reserpine the inotropic action of phentolamine could be blocked; a subsequent infusion of noradrenaline could then restore the inotropic effect. They concluded that the positive inotropic action of phentolamine is indirect and dependent on the release of noradrenaline.
It has recently been shown that phentolamine has P-adrenergic stimulating properties as well as its ac-adrenergic blocking effects. This P-adrenergic stimulating action is suggested by the observation that the fall in blood pressure and the increase in cardiac rate produced by 5 mg of phentolamine can be significantly blocked by the prior administration of propranolol . Propranolol can similarly block the inotropic and chronotropic action of phentolamine in dogs (Singh et al., 1970) . The release of catecholamines following the administration of phentolamine explains the improvement observed in conduction through the atrioventricular node. If phentolamine can increase the availability of endogenous catecholamines to the heart, it is possible that the drug acts, at least in part, in a manner different from most other antiarrhythmic agents. Catecholamines are known to cause hyperpolarisation of partially depolarised or 'sick fibres'. The result is restoration of a normal action potential configuration without significant change in phase 4 (Rosen and Gelband, 1971 
